LifeMD, Inc. — Director's Dealing 2023

Jan 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-01-03

Reporting Person: FRIEDEMAN JESSICA (Chief Marketing Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-03	Common Stock	A	150000	—	Acquired	150000	Direct

Footnotes

F1: Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the reporting person received a grant of 150,000 restricted shares, with 50,000 vesting on January 3, 2024, 50,000 vesting on January 3, 2025 and 50,000 vesting on January 3, 2026.